Man Group plc Takes Position in The Ensign Group, Inc. $ENSG

Man Group plc acquired a new stake in shares of The Ensign Group, Inc. (NASDAQ:ENSG) during the second quarter, according to its most recent filing with the SEC. The fund acquired 25,319 shares of the company’s stock, valued at approximately $4,059,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in The Ensign Group during the 2nd quarter valued at about $937,218,000. Wasatch Advisors LP increased its position in shares of The Ensign Group by 6.0% during the second quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after buying an additional 199,983 shares during the period. Geode Capital Management LLC lifted its holdings in shares of The Ensign Group by 3.4% in the fourth quarter. Geode Capital Management LLC now owns 1,498,673 shares of the company’s stock worth $261,107,000 after buying an additional 49,117 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of The Ensign Group by 9.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,332,505 shares of the company’s stock worth $232,124,000 after buying an additional 118,110 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of The Ensign Group by 0.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,090,838 shares of the company’s stock valued at $190,033,000 after acquiring an additional 5,458 shares during the period. Hedge funds and other institutional investors own 96.12% of the company’s stock.

Insider Buying and Selling at The Ensign Group

In other news, Director Barry M. Smith sold 700 shares of The Ensign Group stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total transaction of $114,996.00. Following the completion of the sale, the director directly owned 21,352 shares of the company’s stock, valued at approximately $3,507,706.56. The trade was a 3.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the company’s stock in a transaction on Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the completion of the transaction, the director owned 9,503 shares of the company’s stock, valued at $1,625,583.18. This trade represents a 3.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.00% of the company’s stock.

The Ensign Group Price Performance

Shares of NASDAQ ENSG opened at $172.98 on Monday. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.06. The business has a 50-day moving average of $173.40 and a 200-day moving average of $184.11. The firm has a market capitalization of $10.08 billion, a price-to-earnings ratio of 27.11, a PEG ratio of 1.66 and a beta of 0.68. The Ensign Group, Inc. has a 12 month low of $141.58 and a 12 month high of $218.00.

The Ensign Group (NASDAQ:ENSG) last announced its earnings results on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.12. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The business had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same period last year, the firm posted $1.59 earnings per share. The Ensign Group’s quarterly revenue was up 16.7% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Sell-side analysts expect that The Ensign Group, Inc. will post 6.93 earnings per share for the current fiscal year.

The Ensign Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th were given a dividend of $0.065 per share. The ex-dividend date was Tuesday, June 30th. This represents a $0.26 annualized dividend and a dividend yield of 0.2%. The Ensign Group’s dividend payout ratio (DPR) is 4.08%.

Wall Street Analysts Forecast Growth

ENSG has been the topic of a number of analyst reports. Weiss Ratings lowered shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Royal Bank Of Canada reissued an “outperform” rating and issued a $228.00 price target on shares of The Ensign Group in a report on Tuesday, July 28th. Truist Financial boosted their price target on shares of The Ensign Group from $202.00 to $207.00 and gave the company a “hold” rating in a research report on Thursday, July 30th. Finally, Wall Street Zen cut shares of The Ensign Group from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Four equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, The Ensign Group currently has an average rating of “Moderate Buy” and a consensus price target of $216.25.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.